福建海西新药创制股份有限公司（02637）于2025年12月2日发布截至2025年11月30日的月度证券变动报告。公告显示，公司于本报告期内注册股本为人民币78,707,270元，面值为每股人民币1元。期末股份总数维持在78,707,270股，未出现新增发行、购回、注销或库藏股活动。
本月报显示，公司普通股H股在香港联交所上市的发行总数与上月相同，且库存股数量保持为零。公告亦指出，当月未有任何股份期权或其他权证、可换股票据的发行或变动。截至11月30日，公司总股本结构稳定，无新增或回购注销等调整。
上述月报由公司联席公司秘书张俊环签署，并确认公司遵守香港联交所《上市规则》及相关法律法规的要求。公司股本及已发行股份状况在报告期内未发生任何变动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.